NAS:BBLGW (USA)
Â
Warrants (13/10/2026)
$
41.62
+8.12 (+24.24%)
02:25 PM EST
Business Description
Bone Biologics Corp
NAICS : 325412
SIC : 3842
Share Class Description:
BBLGW: Warrants (13/10/2026)Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.96 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.5 | |||||
| 3-Year EPS without NRI Growth Rate | 38.1 | |||||
| 3-Year FCF Growth Rate | -0.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 23.27 | |||||
| Quick Ratio | 23.27 | |||||
| Cash Ratio | 19.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -118.6 | |||||
| Shareholder Yield % | -329.97 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -162.03 | |||||
| ROA % | -113.22 | |||||
| ROIC % | -1201.91 | |||||
| ROC (Joel Greenblatt) % | -6088.98 | |||||
| ROCE % | -190.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.45 | |||||
| EV-to-EBIT | 0.2 | |||||
| EV-to-EBITDA | 0.2 | |||||
| EV-to-FCF | 0.15 | |||||
| Earnings Yield (Greenblatt) % | 500 | |||||
| FCF Yield % | -526.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BBLGW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bone Biologics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 46.8 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bone Biologics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bone Biologics Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bone Biologics Corp Frequently Asked Questions
What is Bone Biologics Corp(BBLGW)'s stock price today?
The current price of BBLGW is $41.62. The 52 week high of BBLGW is $46.80 and 52 week low is $0.00.
When is next earnings date of Bone Biologics Corp(BBLGW)?
The next earnings date of Bone Biologics Corp(BBLGW) is 2024-08-14 Est..
Does Bone Biologics Corp(BBLGW) pay dividends? If so, how much?
Bone Biologics Corp(BBLGW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers